TIRZEPATIDE

TIRZEPATIDE was reported 181068 times

These side effects are most commonly reported by patients taking TIRZEPATIDE:

# Side effect Count
0 INCORRECT DOSE ADMINISTERED 32155
1 NAUSEA 19738
2 INJECTION SITE PAIN 14616
3 DIARRHOEA 11312
4 EXTRA DOSE ADMINISTERED 10288
5 OFF LABEL USE 10041
6 VOMITING 9395
7 DRUG INEFFECTIVE 8287
8 CONSTIPATION 7625
9 FATIGUE 5698
10 INJECTION SITE ERYTHEMA 5616
11 INJECTION SITE HAEMORRHAGE 5540
12 PRODUCT DOSE OMISSION ISSUE 5418
13 ACCIDENTAL UNDERDOSE 4610
14 ABDOMINAL PAIN UPPER 4201
15 WEIGHT INCREASED 4035
16 HEADACHE 3999
17 INJECTION SITE BRUISING 3941
18 ILLNESS 3729
19 DIZZINESS 3593
20 DECREASED APPETITE 3472
21 INJECTION SITE PRURITUS 3252
22 ERUCTATION 3216
23 BLOOD GLUCOSE INCREASED 3179
24 ALOPECIA 3066
25 DYSPEPSIA 3016
26 ABDOMINAL PAIN 2892
27 ABDOMINAL DISCOMFORT 2745
28 WEIGHT DECREASED 2596
29 DEHYDRATION 2310
30 INJECTION SITE REACTION 2297
31 THERAPEUTIC RESPONSE CHANGED 2265
32 MALAISE 2237
33 PAIN 2133
34 ACCIDENTAL OVERDOSE 2090
35 GASTROINTESTINAL DISORDER 2071
36 HUNGER 2049
37 INJECTION SITE MASS 2028
38 ABDOMINAL DISTENSION 1988
39 ASTHENIA 1967
40 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1901
41 IMPAIRED GASTRIC EMPTYING 1873
42 INJECTION SITE RASH 1866
43 GASTROOESOPHAGEAL REFLUX DISEASE 1833
44 INJECTION SITE SWELLING 1832
45 FLATULENCE 1771
46 FEELING ABNORMAL 1726
47 ANXIETY 1718
48 INJECTION SITE INJURY 1527
49 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1489
50 RASH 1478
51 PRURITUS 1462
52 PANCREATITIS 1451
53 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1332
54 ARTHRALGIA 1313
55 INJECTION SITE URTICARIA 1309
56 VISUAL IMPAIRMENT 1298
57 INJURY ASSOCIATED WITH DEVICE 1282
58 INCREASED APPETITE 1271
59 BLOOD GLUCOSE DECREASED 1245
60 INTENTIONAL PRODUCT MISUSE 1235
61 INSOMNIA 1224
62 HYPERSENSITIVITY 1195
63 FEEDING DISORDER 1183
64 DEPRESSION 1125
65 DYSPNOEA 1102
66 PRODUCT STORAGE ERROR 1031
67 DEPRESSED MOOD 1016
68 COUGH 1013
69 VISION BLURRED 1000
70 MATERNAL EXPOSURE DURING PREGNANCY 979
71 BACK PAIN 945
72 URTICARIA 909
73 OVERDOSE 901
74 MYALGIA 899
75 NASOPHARYNGITIS 882
76 MUSCLE SPASMS 845
77 PALPITATIONS 844
78 GLYCOSYLATED HAEMOGLOBIN INCREASED 831
79 CHOLELITHIASIS 820
80 HYPOGLYCAEMIA 812
81 FOOD CRAVING 794
82 PAIN IN EXTREMITY 788
83 FALL 768
84 DRUG INTERACTION 730
85 HEART RATE INCREASED 708
86 INTESTINAL OBSTRUCTION 681
87 TREMOR 679
88 DRUG HYPERSENSITIVITY 673
89 COVID-19 659
90 INFLUENZA 624
91 DRY MOUTH 613
92 PRODUCT USE ISSUE 611
93 SOMNOLENCE 608
94 INTERCEPTED PRODUCT SELECTION ERROR 606
95 HYPOTENSION 600
96 MIGRAINE 599
97 INJECTION SITE HYPERSENSITIVITY 591
98 INTERCEPTED PRODUCT DISPENSING ERROR 589
99 BLOOD PRESSURE INCREASED 588
100 PARAESTHESIA 586
101 ACUTE KIDNEY INJURY 583
102 HYPOPHAGIA 582
103 NO ADVERSE EVENT 579
104 CHILLS 573
105 INJECTION SITE IRRITATION 571
106 UNDERDOSE 566
107 SYNCOPE 559
108 CHEST PAIN 550
109 URINARY TRACT INFECTION 543
110 PYREXIA 535
111 DRUG INTOLERANCE 526
112 SUICIDAL IDEATION 509
113 PRODUCT DISPENSING ERROR 490
114 HYPERHIDROSIS 488
115 LOSS OF CONSCIOUSNESS 487
116 HYPOAESTHESIA 476
117 DEATH 475
118 INJECTION SITE DISCOMFORT 471
119 BLOOD PRESSURE DECREASED 469
120 PRODUCT TAMPERING 468
121 LETHARGY 459
122 PERIPHERAL SWELLING 444
123 GAIT DISTURBANCE 437
124 PANIC ATTACK 421
125 BRAIN FOG 411
126 DYSGEUSIA 401
127 INFLUENZA LIKE ILLNESS 401
128 GASTROINTESTINAL HYPOMOTILITY 387
129 BLOOD GLUCOSE ABNORMAL 385
130 NECK PAIN 381
131 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 380
132 HYPERTENSION 378
133 TACHYCARDIA 376
134 ERYTHEMA 375
135 DISCOMFORT 366
136 PANCREATITIS ACUTE 365
137 ATRIAL FIBRILLATION 363
138 NEPHROLITHIASIS 359
139 INJECTION SITE WARMTH 356
140 CATARACT 352
141 PRODUCT STORAGE ISSUE 352
142 PNEUMONIA 349
143 CONTUSION 346
144 PRODUCT USE IN UNAPPROVED INDICATION 345
145 MUSCULAR WEAKNESS 336
146 CEREBROVASCULAR ACCIDENT 332
147 MEMORY IMPAIRMENT 332
148 ILEUS 331
149 MOBILITY DECREASED 330
150 VERTIGO 326
151 SINUSITIS 322
152 DYSPHAGIA 321
153 LIPASE INCREASED 320
154 TASTE DISORDER 319
155 HYPOACUSIS 318
156 GASTRITIS 317
157 CHEST DISCOMFORT 316
158 INJECTION SITE COLDNESS 316
159 OROPHARYNGEAL PAIN 316
160 GALLBLADDER DISORDER 312
161 GASTROENTERITIS VIRAL 309
162 RENAL IMPAIRMENT 309
163 ANAPHYLACTIC REACTION 308
164 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 308
165 MUSCLE ATROPHY 306
166 MYOCARDIAL INFARCTION 303
167 INJECTION SITE VESICLES 301
168 SWELLING 300
169 DYSPHONIA 298
170 FEELING COLD 297
171 HEPATIC ENZYME INCREASED 293
172 HOT FLUSH 288
173 BURNING SENSATION 287
174 NEUROPATHY PERIPHERAL 285
175 CONDITION AGGRAVATED 283
176 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 283
177 DRY SKIN 279
178 RASH PRURITIC 275
179 LYMPHADENOPATHY 270
180 CHOLECYSTITIS 264
181 STRESS 264
182 RETCHING 261
183 ALANINE AMINOTRANSFERASE INCREASED 260
184 SENSITIVE SKIN 260
185 ASTHMA 258
186 ACCIDENTAL EXPOSURE TO PRODUCT 257
187 FLUID INTAKE REDUCED 255
188 GASTROINTESTINAL SOUNDS ABNORMAL 255
189 CONFUSIONAL STATE 253
190 SLEEP DISORDER 249
191 PAIN OF SKIN 247
192 INFECTION 246
193 VAGINAL HAEMORRHAGE 244
194 COLITIS 243
195 RENAL FAILURE 239
196 SEPSIS 238
197 TREATMENT FAILURE 234
198 CARDIAC DISORDER 230
199 PULMONARY EMBOLISM 228
200 DIABETIC KETOACIDOSIS 227
201 PRODUCT PRESCRIBING ERROR 227
202 ARTHRITIS 224
203 POLLAKIURIA 224
204 BLINDNESS 222
205 SEIZURE 222
206 GASTROINTESTINAL PAIN 220
207 APPENDICITIS 216
208 DIVERTICULITIS 214
209 DRY EYE 209
210 SKIN BURNING SENSATION 209
211 RENAL DISORDER 206
212 ABORTION SPONTANEOUS 205
213 INJECTION SITE DISCOLOURATION 203
214 FEELING HOT 202
215 THIRST 202
216 PRESYNCOPE 201
217 LIP SWELLING 200
218 INSURANCE ISSUE 198
219 INTENTIONAL DOSE OMISSION 198
220 JOINT SWELLING 197
221 THROAT IRRITATION 197
222 INFLAMMATION 194
223 NEOPLASM MALIGNANT 191
224 RHINORRHOEA 191
225 BALANCE DISORDER 190
226 EYE PAIN 190
227 IRRITABILITY 189
228 OPTIC ISCHAEMIC NEUROPATHY 187
229 INJECTION SITE INDURATION 186
230 VIRAL INFECTION 186
231 INTERCEPTED PRODUCT PRESCRIBING ERROR 185
232 SMALL INTESTINAL OBSTRUCTION 185
233 SWELLING FACE 184
234 ANGIOEDEMA 181
235 PSORIASIS 181
236 MALNUTRITION 180
237 BLOOD CREATININE INCREASED 179
238 BLOOD POTASSIUM DECREASED 179
239 BREAST CANCER 179
240 MUSCULOSKELETAL STIFFNESS 179
241 THERAPY NON-RESPONDER 179
242 GASTROENTERITIS 178
243 HAEMATOCHEZIA 178
244 FREQUENT BOWEL MOVEMENTS 177
245 THERAPEUTIC PRODUCT EFFECT DECREASED 177
246 VOMITING PROJECTILE 177
247 WEIGHT FLUCTUATION 177
248 BLOOD CHOLESTEROL INCREASED 176
249 FOOD POISONING 174
250 EYE IRRITATION 172
251 ALLODYNIA 171
252 DEEP VEIN THROMBOSIS 171
253 HERPES ZOSTER 171
254 INJECTION SITE PARAESTHESIA 171
255 SKIN EXFOLIATION 171
256 HAEMORRHAGE 170
257 NASAL CONGESTION 166
258 TINNITUS 165
259 FLUSHING 164
260 MEDICATION ERROR 164
261 ASPARTATE AMINOTRANSFERASE INCREASED 163
262 THERAPY INTERRUPTED 161
263 BLOOD GLUCOSE FLUCTUATION 160
264 ECZEMA 157
265 RASH ERYTHEMATOUS 155
266 THERAPY CESSATION 155
267 INJECTION SITE INFLAMMATION 154
268 MENTAL DISORDER 154
269 DIABETES MELLITUS 153
270 GLOMERULAR FILTRATION RATE DECREASED 153
271 HAEMATEMESIS 153
272 MOOD ALTERED 153
273 NERVOUSNESS 152
274 THROMBOSIS 152
275 ROAD TRAFFIC ACCIDENT 151
276 KETOACIDOSIS 150
277 COLD SWEAT 148
278 DERMATITIS ATOPIC 148
279 OBSTRUCTIVE PANCREATITIS 147
280 SLEEP APNOEA SYNDROME 147
281 POSTMENOPAUSAL HAEMORRHAGE 145
282 EMOTIONAL DISTRESS 144
283 POOR QUALITY SLEEP 144
284 ANAEMIA 143
285 HYPOKALAEMIA 143
286 BOWEL MOVEMENT IRREGULARITY 142
287 COLITIS ISCHAEMIC 142
288 EYE DISORDER 142
289 FLUID RETENTION 142
290 BRONCHITIS 141
291 DEVICE DIFFICULT TO USE 140
292 THYROID MASS 140
293 HEPATIC STEATOSIS 138
294 NEURALGIA 138
295 RECTAL HAEMORRHAGE 138
296 WRONG PATIENT RECEIVED PRODUCT 138
297 BILIARY COLIC 137
298 FEELING JITTERY 137
299 PANCREATIC CARCINOMA 137
300 HERNIA 136
301 IRRITABLE BOWEL SYNDROME 136
302 HEAVY MENSTRUAL BLEEDING 134
303 OEDEMA PERIPHERAL 133
304 GAIT INABILITY 132
305 AMYLASE INCREASED 131
306 BONE PAIN 131
307 JAUNDICE 131
308 EUGLYCAEMIC DIABETIC KETOACIDOSIS 130
309 DRUG EFFECT LESS THAN EXPECTED 129
310 RHEUMATOID ARTHRITIS 129
311 DISTURBANCE IN ATTENTION 125
312 FAECES DISCOLOURED 125
313 DRUG DOSE OMISSION BY DEVICE 124
314 METABOLIC ACIDOSIS 123
315 ANAPHYLACTIC SHOCK 122
316 EPISTAXIS 122
317 HYPERSOMNIA 122
318 DRUG TITRATION ERROR 120
319 HEAD INJURY 120
320 THERAPEUTIC RESPONSE SHORTENED 120
321 CHOLECYSTITIS ACUTE 119
322 AGEUSIA 116
323 HICCUPS 116
324 CHROMATURIA 115
325 EATING DISORDER 115
326 EXPOSURE VIA SKIN CONTACT 115
327 MUSCULOSKELETAL CHEST PAIN 115
328 SURGERY 115
329 ABDOMINAL PAIN LOWER 114
330 FUNGAL INFECTION 114
331 NIGHT SWEATS 113
332 OCULAR HYPERAEMIA 113
333 DRUG TITRATION ISSUE 112
334 SEASONAL ALLERGY 110
335 SPEECH DISORDER 110
336 CARDIAC ARREST 109
337 EYE SWELLING 109
338 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109
339 SKIN DISCOLOURATION 109
340 THERAPY CHANGE 108
341 WEIGHT LOSS POOR 108
342 LIMB INJURY 107
343 RENAL PAIN 107
344 THYROID CANCER 107
345 UPPER RESPIRATORY TRACT INFECTION 107
346 HEPATITIS 106
347 THROAT TIGHTNESS 106
348 AMNESIA 105
349 DRUG DOSE TITRATION NOT PERFORMED 105
350 LIVER FUNCTION TEST ABNORMAL 105
351 PARAESTHESIA ORAL 105
352 SKIN IRRITATION 105
353 SWOLLEN TONGUE 105
354 ARRHYTHMIA 104
355 LACTIC ACIDOSIS 104
356 LIMB DISCOMFORT 104
357 BLINDNESS UNILATERAL 103
358 INTERCEPTED PRODUCT STORAGE ERROR 103
359 THERAPEUTIC RESPONSE DECREASED 103
360 WHITE BLOOD CELL COUNT INCREASED 103
361 EYE PRURITUS 102
362 THYROID DISORDER 102
363 BLOOD PRESSURE ABNORMAL 101
364 LIVER INJURY 101
365 GOUT 99
366 OFF LABEL USE OF DEVICE 99
367 PRODUCT DOSE OMISSION IN ERROR 99
368 PRODUCTIVE COUGH 99
369 SNEEZING 99
370 APPETITE DISORDER 98
371 DIZZINESS POSTURAL 98
372 LIVER DISORDER 98
373 SLUGGISHNESS 98
374 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 98
375 ARTHROPATHY 97
376 CHRONIC KIDNEY DISEASE 97
377 FOOD AVERSION 97
378 INTERMENSTRUAL BLEEDING 97
379 PSORIATIC ARTHROPATHY 97
380 CARDIAC FAILURE 96
381 CELLULITIS 96
382 OROPHARYNGEAL DISCOMFORT 96
383 PANCREATIC DISORDER 96
384 HYPERTHYROIDISM 95
385 SKIN REACTION 95
386 ADVERSE DRUG REACTION 94
387 ELECTROLYTE IMBALANCE 93
388 GENERAL PHYSICAL HEALTH DETERIORATION 93
389 AGITATION 92
390 DIABETES MELLITUS INADEQUATE CONTROL 92
391 HYPERPHAGIA 92
392 SENSATION OF FOREIGN BODY 92
393 COGNITIVE DISORDER 91
394 PAIN IN JAW 91
395 PHARYNGEAL SWELLING 90
396 WRONG PRODUCT ADMINISTERED 90
397 MOOD SWINGS 89
398 INJECTION SITE INDENTATION 88
399 RASH MACULAR 88
400 HAEMORRHOIDS 87
401 HYPOAESTHESIA ORAL 87
402 KIDNEY INFECTION 87
403 DISORIENTATION 86
404 DYSSTASIA 86
405 INJECTION SITE HYPOAESTHESIA 86
406 LIVER FUNCTION TEST INCREASED 86
407 TRANSIENT ISCHAEMIC ATTACK 86
408 ANGER 85
409 MUSCULOSKELETAL DISCOMFORT 85
410 OSTEOARTHRITIS 85
411 TOXICITY TO VARIOUS AGENTS 85
412 VITREOUS FLOATERS 85
413 DIPLOPIA 84
414 BLISTER 83
415 MENSTRUATION IRREGULAR 83
416 PAROSMIA 83
417 EAR INFECTION 82
418 GLYCOSYLATED HAEMOGLOBIN DECREASED 82
419 ORTHOSTATIC HYPOTENSION 82
420 HYPERKALAEMIA 81
421 NIGHTMARE 81
422 GAMMA-GLUTAMYLTRANSFERASE INCREASED 80
423 MIDDLE INSOMNIA 80
424 PERIPHERAL COLDNESS 80
425 HIATUS HERNIA 78
426 ILEUS PARALYTIC 78
427 INJURY 78
428 PANCREATIC ENZYMES INCREASED 78
429 BLOOD TRIGLYCERIDES INCREASED 77
430 DECREASED ACTIVITY 77
431 DRUG-INDUCED LIVER INJURY 77
432 INJECTION SITE SCAR 77
433 MENSTRUATION DELAYED 77
434 ACNE 76
435 APATHY 76
436 CRYING 76
437 HEART RATE DECREASED 76
438 HYPONATRAEMIA 76
439 PROCEDURAL PAIN 76
440 ABNORMAL LOSS OF WEIGHT 75
441 BLOOD BILIRUBIN INCREASED 75
442 EARLY SATIETY 75
443 GASTROINTESTINAL MOTILITY DISORDER 75
444 INTESTINAL ISCHAEMIA 75
445 ABNORMAL DREAMS 74
446 DYSURIA 74
447 URINARY RETENTION 74
448 WHEEZING 74
449 ANAL INCONTINENCE 73
450 HOSPITALISATION 73
451 HYPERGLYCAEMIA 73
452 MASS 73
453 OEDEMA 73
454 OXYGEN SATURATION DECREASED 73
455 PRODUCT DISPENSING ISSUE 73
456 BLOOD SODIUM DECREASED 72
457 HEAD DISCOMFORT 72
458 RESTLESSNESS 72
459 DEVICE ISSUE 71
460 DIABETIC RETINOPATHY 71
461 FIBROMYALGIA 71
462 FOETAL EXPOSURE DURING PREGNANCY 71
463 GASTROINTESTINAL HAEMORRHAGE 71
464 INCORRECT PRODUCT FORMULATION ADMINISTERED 71
465 PRODUCT COMMUNICATION ISSUE 71
466 REGURGITATION 71
467 RHABDOMYOLYSIS 71
468 MULTIPLE ORGAN DYSFUNCTION SYNDROME 70
469 BLOOD URINE PRESENT 69
470 DYSPNOEA EXERTIONAL 69
471 ERECTILE DYSFUNCTION 69
472 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 69
473 INTENTIONAL PRODUCT USE ISSUE 69
474 HYPERAESTHESIA 68
475 LACRIMATION INCREASED 68
476 PANCREATITIS NECROTISING 68
477 PAPILLARY THYROID CANCER 68
478 BLOOD ALKALINE PHOSPHATASE INCREASED 67
479 FAECALOMA 67
480 CHOLANGITIS 66
481 DEPRESSION SUICIDAL 66
482 HEPATIC CIRRHOSIS 66
483 NECK MASS 66
484 URINE OUTPUT DECREASED 66
485 RETINAL DETACHMENT 65
486 SINUS DISORDER 65
487 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 65
488 DERMATITIS ALLERGIC 64
489 EXPIRED PRODUCT ADMINISTERED 64
490 JOINT INJURY 64
491 MUSCLE TWITCHING 64
492 SCIATICA 64
493 SKIN FISSURES 64
494 BILE DUCT STONE 63
495 DEVICE MALFUNCTION 63
496 FAECES HARD 63
497 FOOT FRACTURE 63
498 POST PROCEDURAL COMPLICATION 63
499 BLINDNESS TRANSIENT 62
500 GASTRIC HYPOMOTILITY 62
501 STOMATITIS 62
502 BLOOD IRON DECREASED 61
503 C-REACTIVE PROTEIN INCREASED 61
504 CHOLECYSTITIS INFECTIVE 61
505 RETINOPATHY 61
506 SYSTEMIC LUPUS ERYTHEMATOSUS 61
507 FACIAL PAIN 60
508 HYPOTHYROIDISM 60
509 LYMPH NODE PAIN 60
510 MUSCULOSKELETAL PAIN 60
511 WHITE BLOOD CELL COUNT DECREASED 60
512 ACCIDENT 59
513 CARPAL TUNNEL SYNDROME 59
514 MENSTRUAL DISORDER 59
515 MUSCLE TIGHTNESS 59
516 SKIN LAXITY 59
517 STARVATION KETOACIDOSIS 59
518 ANKLE FRACTURE 58
519 APHONIA 58
520 DYSAESTHESIA 58
521 DYSARTHRIA 58
522 LIBIDO DECREASED 58
523 NOCTURIA 58
524 RESPIRATORY TRACT INFECTION 58
525 BACK DISORDER 57
526 COLITIS ULCERATIVE 57
527 FLANK PAIN 57
528 INJECTION SITE INFECTION 57
529 LOCALISED INFECTION 57
530 MENTAL IMPAIRMENT 57
531 OCULAR DISCOMFORT 57
532 RASH PAPULAR 57
533 SEPTIC SHOCK 57
534 SKIN DISORDER 57
535 EAR PAIN 56
536 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 56
537 INTERVERTEBRAL DISC PROTRUSION 56
538 KETOSIS 56
539 PERONEAL NERVE PALSY 56
540 UPPER-AIRWAY COUGH SYNDROME 56
541 NEOPLASM 55
542 LARYNGITIS 54
543 NERVOUS SYSTEM DISORDER 54
544 PLATELET COUNT DECREASED 54
545 TYPE 2 DIABETES MELLITUS 54
546 URINARY INCONTINENCE 54
547 ABDOMINAL RIGIDITY 53
548 ANHEDONIA 53
549 BLOOD POTASSIUM INCREASED 53
550 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53
551 INJECTION SITE HAEMATOMA 53
552 RESTLESS LEGS SYNDROME 53
553 ASPIRATION 52
554 BILIARY OBSTRUCTION 52
555 CHOKING 52
556 CROHN^S DISEASE 52
557 CYSTITIS 52
558 DIARRHOEA HAEMORRHAGIC 52
559 INJECTION SITE NODULE 52
560 ORAL PAIN 52
561 UNEVALUABLE EVENT 52
562 WOUND 52
563 APPENDICITIS PERFORATED 51
564 BREATH ODOUR 51
565 DEAFNESS 51
566 GASTROINTESTINAL INFECTION 51
567 HALLUCINATION 51
568 PHOTOPHOBIA 51
569 BLOOD MAGNESIUM DECREASED 50
570 EYE HAEMORRHAGE 50
571 PSYCHOTIC DISORDER 50
572 RESPIRATORY DISORDER 50
573 SCRATCH 50
574 TENDERNESS 50
575 THINKING ABNORMAL 50
576 ADVERSE EVENT 49
577 CARDIAC FAILURE CONGESTIVE 49
578 GALLBLADDER INJURY 49
579 GOITRE 49
580 HAEMOGLOBIN DECREASED 49
581 HYPOVOLAEMIA 49
582 MULTIPLE SCLEROSIS 49
583 PHARYNGITIS STREPTOCOCCAL 49
584 RIB FRACTURE 49
585 ABDOMINAL TENDERNESS 48
586 ACUTE MYOCARDIAL INFARCTION 48
587 AMENORRHOEA 48
588 BIPOLAR DISORDER 48
589 COUNTERFEIT PRODUCT ADMINISTERED 48
590 DYSMENORRHOEA 48
591 HEART RATE IRREGULAR 48
592 INITIAL INSOMNIA 48
593 SUNBURN 48
594 THROAT CLEARING 48
595 VENTRICULAR EXTRASYSTOLES 48
596 CONCUSSION 47
597 EAR DISCOMFORT 47
598 LUNG DISORDER 47
599 MICTURITION URGENCY 47
600 ORAL HERPES 47
601 PRODUCT QUALITY ISSUE 47
602 SKIN HAEMORRHAGE 47
603 UPPER LIMB FRACTURE 47
604 BLOOD THYROID STIMULATING HORMONE INCREASED 46
605 DRY THROAT 46
606 EMOTIONAL DISORDER 46
607 HYPOXIA 46
608 SUSPECTED COUNTERFEIT PRODUCT 46
609 TOOTHACHE 46
610 APHASIA 45
611 ASTHENOPIA 45
612 DERMATITIS CONTACT 45
613 DRUG WITHDRAWAL SYNDROME 45
614 HEPATIC FUNCTION ABNORMAL 45
615 INFREQUENT BOWEL MOVEMENTS 45
616 PALLOR 45
617 PRODUCT ADMINISTRATION INTERRUPTED 45
618 RETINAL HAEMORRHAGE 45
619 SUPRAVENTRICULAR TACHYCARDIA 45
620 HYPERCALCAEMIA 44
621 LOWER LIMB FRACTURE 44
622 MACULAR DEGENERATION 44
623 MYASTHENIA GRAVIS 44
624 OESOPHAGITIS 44
625 SKIN LESION 44
626 THROMBOCYTOPENIA 44
627 AUTOIMMUNE DISORDER 43
628 GLAUCOMA 43
629 INCORRECT DOSE ADMINISTERED BY DEVICE 43
630 INTESTINAL PERFORATION 43
631 LYMPHOEDEMA 43
632 NERVE INJURY 43
633 THERAPEUTIC RESPONSE UNEXPECTED 43
634 ELECTRIC SHOCK SENSATION 42
635 HAEMOGLOBIN INCREASED 42
636 OBESITY 42
637 PANCREATIC CYST 42
638 PLEURAL EFFUSION 42
639 PRODUCT PRESCRIBING ISSUE 42
640 RESPIRATORY FAILURE 42
641 SKIN LACERATION 42
642 CARDIAC FLUTTER 41
643 COLON CANCER 41
644 DERMATITIS 41
645 GASTRIC ULCER 41
646 GASTROINTESTINAL INFLAMMATION 41
647 JOINT STIFFNESS 41
648 MANIA 41
649 NERVE COMPRESSION 41
650 PNEUMONIA ASPIRATION 41
651 PRODUCT AVAILABILITY ISSUE 41
652 SPINAL FRACTURE 41
653 ABNORMAL FAECES 40
654 CANDIDA INFECTION 40
655 DEFAECATION URGENCY 40
656 DEMENTIA 40
657 INJECTION SITE DISCHARGE 40
658 LOWER RESPIRATORY TRACT INFECTION 40
659 OPTIC NEURITIS 40
660 BLOOD PRESSURE FLUCTUATION 39
661 CYST 39
662 HORMONE LEVEL ABNORMAL 39
663 IMPAIRED QUALITY OF LIFE 39
664 INFUSION SITE PAIN 39
665 PHOTOSENSITIVITY REACTION 39
666 PRODUCT SUBSTITUTION ISSUE 39
667 SALIVARY HYPERSECRETION 39
668 CEREBRAL HAEMORRHAGE 38
669 DISEASE RECURRENCE 38
670 INFUSION RELATED REACTION 38
671 POLYMENORRHOEA 38
672 SCAR 38
673 CARDIOVASCULAR DISORDER 37
674 CONTRAINDICATED PRODUCT ADMINISTERED 37
675 DELIRIUM 37
676 HIP FRACTURE 37
677 SKIN SWELLING 37
678 STARVATION 37
679 TREATMENT NONCOMPLIANCE 37
680 AGGRESSION 36
681 DYSCHEZIA 36
682 IMPAIRED WORK ABILITY 36
683 MEDULLARY THYROID CANCER 36
684 MOVEMENT DISORDER 36
685 MUSCLE STRAIN 36
686 PARANOIA 36
687 PRESCRIBED OVERDOSE 36
688 PRODUCT AFTER TASTE 36
689 PULMONARY OEDEMA 36
690 RENAL INJURY 36
691 SINUS CONGESTION 36
692 BRADYCARDIA 35
693 CLOSTRIDIUM DIFFICILE INFECTION 35
694 DEVICE DEFECTIVE 35
695 DEVICE LEAKAGE 35
696 ENTERITIS 35
697 EXPOSURE DURING PREGNANCY 35
698 FOOD INTOLERANCE 35
699 GLOSSODYNIA 35
700 HEPATIC FAILURE 35
701 INCORRECT PRODUCT ADMINISTRATION DURATION 35
702 INJECTION SITE CELLULITIS 35
703 LOW DENSITY LIPOPROTEIN INCREASED 35
704 MATERNAL EXPOSURE DURING BREAST FEEDING 35
705 MENISCUS INJURY 35
706 MOUTH ULCERATION 35
707 NEEDLE ISSUE 35
708 OSTEOPOROSIS 35
709 PARALYSIS 35
710 SKIN MASS 35
711 ANGINA PECTORIS 34
712 ARTHROPOD BITE 34
713 BLOOD UREA INCREASED 34
714 ENERGY INCREASED 34
715 GASTRIC DILATATION 34
716 INTENTIONAL UNDERDOSE 34
717 NOROVIRUS INFECTION 34
718 PERIORBITAL SWELLING 34
719 TENDON RUPTURE 34
720 VITAMIN D DECREASED 34
721 VITAMIN D DEFICIENCY 34
722 WITHDRAWAL SYNDROME 34
723 BELL^S PALSY 33
724 BREAST PAIN 33
725 GROIN PAIN 33
726 HEART RATE ABNORMAL 33
727 LIGAMENT SPRAIN 33
728 LUNG NEOPLASM MALIGNANT 33
729 METABOLIC DISORDER 33
730 OBSESSIVE-COMPULSIVE DISORDER 33
731 PRODUCT PREPARATION ERROR 33
732 ROTATOR CUFF SYNDROME 33
733 SKIN ODOUR ABNORMAL 33
734 SKIN SENSITISATION 33
735 TENDONITIS 33
736 DECREASED INTEREST 32
737 DRUG RESISTANCE 32
738 DYSKINESIA 32
739 EYE DISCHARGE 32
740 EYE INFECTION 32
741 FEAR OF INJECTION 32
742 GASTRIC PH DECREASED 32
743 NEUTROPENIA 32
744 OCULAR ICTERUS 32
745 PANCREATITIS CHRONIC 32
746 POST-TRAUMATIC STRESS DISORDER 32
747 PRODUCT ADMINISTRATION ERROR 32
748 RENAL CYST 32
749 SELF-INJURIOUS IDEATION 32
750 URINE ODOUR ABNORMAL 32
751 VITREOUS DETACHMENT 32
752 ACIDOSIS 31
753 BACTERIAL INFECTION 31
754 CEREBRAL DISORDER 31
755 CONJUNCTIVITIS 31
756 FEELING OF DESPAIR 31
757 FOOD ALLERGY 31
758 GLUCOSE TOLERANCE IMPAIRED 31
759 HIDRADENITIS 31
760 IMPAIRED HEALING 31
761 ORAL CANDIDIASIS 31
762 PROSTATE CANCER 31
763 SKIN ULCER 31
764 TOOTH DISORDER 31
765 VITAMIN B12 DEFICIENCY 31
766 VOLVULUS 31
767 ANAL FISSURE 30
768 CEREBRAL INFARCTION 30
769 COMPLETED SUICIDE 30
770 CYCLIC VOMITING SYNDROME 30
771 EPIGASTRIC DISCOMFORT 30
772 EPILEPSY 30
773 FEAR 30
774 INTRUSIVE THOUGHTS 30
775 MACULAR OEDEMA 30
776 MULTIPLE ALLERGIES 30
777 PERICARDIAL EFFUSION 30
778 PHOTOPSIA 30
779 PRESCRIBED UNDERDOSE 30
780 RETINAL ARTERY OCCLUSION 30
781 SUICIDE ATTEMPT 30
782 TEMPERATURE INTOLERANCE 30
783 TOOTH INFECTION 30
784 BACK INJURY 29
785 BLOOD THYROID STIMULATING HORMONE DECREASED 29
786 BODY MASS INDEX INCREASED 29
787 CHOLECYSTECTOMY 29
788 DIVERTICULUM INTESTINAL 29
789 GENERALISED OEDEMA 29
790 HAIR TEXTURE ABNORMAL 29
791 HYPERCHLORHYDRIA 29
792 INJECTION SITE LACERATION 29
793 ISCHAEMIC STROKE 29
794 LACK OF SATIETY 29
795 ORAL DISCOMFORT 29
796 PRODUCT COMPLAINT 29
797 SPINAL PAIN 29
798 SPINAL STENOSIS 29
799 THIRST DECREASED 29
800 ULCER 29
801 ABNORMAL BEHAVIOUR 28
802 BLEPHAROSPASM 28
803 BLOOD CALCIUM INCREASED 28
804 DEVICE USE ERROR 28
805 DISCOLOURED VOMIT 28
806 ENDOMETRIOSIS 28
807 FEELING OF BODY TEMPERATURE CHANGE 28
808 FRACTURE 28
809 GALLBLADDER ENLARGEMENT 28
810 GENERALISED TONIC-CLONIC SEIZURE 28
811 LARGE INTESTINAL OBSTRUCTION 28
812 MAJOR DEPRESSION 28
813 MUSCULOSKELETAL DISORDER 28
814 NODULE 28
815 PANIC REACTION 28
816 SECRETION DISCHARGE 28
817 TOOTH FRACTURE 28
818 ASCITES 27
819 BRAIN NEOPLASM 27
820 COMA 27
821 DEAFNESS UNILATERAL 27
822 ONYCHOCLASIS 27
823 OPHTHALMIC MIGRAINE 27
824 RED BLOOD CELL COUNT INCREASED 27
825 RENAL FUNCTION TEST ABNORMAL 27
826 SHOCK 27
827 SLEEP DEFICIT 27
828 SWELLING OF EYELID 27
829 UTERINE LEIOMYOMA 27
830 WRONG DOSE 27
831 ANOSMIA 26
832 ATTENTION DEFICIT HYPERACTIVITY DISORDER 26
833 CHOLESTASIS 26
834 CORTISOL INCREASED 26
835 FACIAL PARALYSIS 26
836 FAECES SOFT 26
837 FRUSTRATION TOLERANCE DECREASED 26
838 GRAVES^ DISEASE 26
839 HAEMATURIA 26
840 IMMUNE SYSTEM DISORDER 26
841 MALABSORPTION 26
842 OBSTRUCTIVE SLEEP APNOEA SYNDROME 26
843 ODYNOPHAGIA 26
844 PANIC DISORDER 26
845 POLYP 26
846 RETINAL TEAR 26
847 SCAB 26
848 SENSORY DISTURBANCE 26
849 SKIN WRINKLING 26
850 SPINAL DISORDER 26
851 TENSION HEADACHE 26
852 WRIST FRACTURE 26
853 BINGE EATING 25
854 BLOOD PRESSURE DIASTOLIC INCREASED 25
855 BLOOD PRESSURE SYSTOLIC DECREASED 25
856 BRAIN INJURY 25
857 DECREASED IMMUNE RESPONSIVENESS 25
858 DUODENOGASTRIC REFLUX 25
859 FUNCTIONAL GASTROINTESTINAL DISORDER 25
860 GINGIVAL PAIN 25
861 HAEMOPTYSIS 25
862 INFUSION SITE ERYTHEMA 25
863 INJECTION SITE SCAB 25
864 LIP DRY 25
865 MENTAL STATUS CHANGES 25
866 MOTION SICKNESS 25
867 PYELONEPHRITIS 25
868 RESPIRATORY TRACT CONGESTION 25
869 SINUS TACHYCARDIA 25
870 AUTOIMMUNE THYROIDITIS 24
871 BLADDER DISORDER 24
872 BLOOD TEST ABNORMAL 24
873 BODY TEMPERATURE INCREASED 24
874 DEVICE DELIVERY SYSTEM ISSUE 24
875 DRUG DEPENDENCE 24
876 DYSENTERY 24
877 HYPOGLYCAEMIC UNCONSCIOUSNESS 24
878 INJECTION SITE PUSTULE 24
879 JOINT DISLOCATION 24
880 LEUKOCYTOSIS 24
881 MUSCLE FATIGUE 24
882 OESOPHAGEAL SPASM 24
883 PARANASAL SINUS HYPERSECRETION 24
884 PELVIC PAIN 24
885 PEMPHIGOID 24
886 PERITONITIS 24
887 PERSONALITY CHANGE 24
888 POST PROCEDURAL INFECTION 24
889 PROTEIN TOTAL DECREASED 24
890 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24
891 SERUM FERRITIN INCREASED 24
892 SKIN ABRASION 24
893 SKIN INFECTION 24
894 SPLENOMEGALY 24
895 STAPHYLOCOCCAL INFECTION 24
896 TRANSAMINASES INCREASED 24
897 ATRIAL FLUTTER 23
898 BLOOD CALCIUM DECREASED 23
899 BURSITIS 23
900 CORONARY ARTERY DISEASE 23
901 GINGIVAL BLEEDING 23
902 INFLAMMATORY MARKER INCREASED 23
903 KNEE ARTHROPLASTY 23
904 MELAENA 23
905 MENOPAUSE 23
906 PULMONARY MASS 23
907 RAYNAUD^S PHENOMENON 23
908 RED BLOOD CELL COUNT DECREASED 23
909 SKIN ATROPHY 23
910 SPINAL OPERATION 23
911 TONGUE DISCOMFORT 23
912 VISUAL FIELD DEFECT 23
913 VITAMIN B12 DECREASED 23
914 YELLOW SKIN 23
915 ACUTE ABDOMEN 22
916 ACUTE CHOLECYSTITIS NECROTIC 22
917 BLOOD INSULIN INCREASED 22
918 BLOOD PHOSPHORUS DECREASED 22
919 CIRCULATORY COLLAPSE 22
920 DEVICE BREAKAGE 22
921 GASTRIC HAEMORRHAGE 22
922 HAEMATOMA 22
923 HEPATOMEGALY 22
924 INFUSION SITE SWELLING 22
925 INTENTIONAL OVERDOSE 22
926 LARGE INTESTINE PERFORATION 22
927 POLYURIA 22
928 PROTEINURIA 22
929 SKIN WARM 22
930 TRICHORRHEXIS 22
931 URINE ABNORMALITY 22
932 VASCULITIS 22
933 BLOOD ALBUMIN DECREASED 21
934 BLOOD CREATINE PHOSPHOKINASE INCREASED 21
935 BLOOD TESTOSTERONE DECREASED 21
936 BRADYKINESIA 21
937 CHAPPED LIPS 21
938 CORONARY ARTERY OCCLUSION 21
939 DENTAL CARIES 21
940 ECTOPIC PREGNANCY 21
941 ENCEPHALOPATHY 21
942 ESCHERICHIA INFECTION 21
943 EYE INFLAMMATION 21
944 HAND FRACTURE 21
945 HELICOBACTER INFECTION 21
946 HEPATIC PAIN 21
947 INCORRECT DOSAGE ADMINISTERED 21
948 INFUSION SITE HAEMORRHAGE 21
949 INTRAOCULAR PRESSURE INCREASED 21
950 LYMPHOMA 21
951 MOUTH SWELLING 21
952 MUCOUS STOOLS 21
953 OESOPHAGEAL PAIN 21
954 OSTEOPENIA 21
955 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 21
956 PRODUCT PREPARATION ISSUE 21
957 PULMONARY CONGESTION 21
958 QUALITY OF LIFE DECREASED 21
959 THYROIDITIS 21
960 UMBILICAL HERNIA 21
961 VENTRICULAR TACHYCARDIA 21
962 ARTERIOSCLEROSIS CORONARY ARTERY 20
963 BLOOD ELECTROLYTES DECREASED 20
964 BLOOD KETONE BODY INCREASED 20
965 DEPRESSED LEVEL OF CONSCIOUSNESS 20
966 DIABETIC NEUROPATHY 20
967 DRUG LEVEL INCREASED 20
968 GASTROINTESTINAL NECROSIS 20
969 HEPATIC CANCER 20
970 HEREDITARY ANGIOEDEMA 20
971 INJECTION SITE DRYNESS 20
972 INSULIN RESISTANCE 20
973 LABORATORY TEST ABNORMAL 20
974 PETECHIAE 20
975 PRODUCT DISTRIBUTION ISSUE 20
976 RETINAL VEIN OCCLUSION 20
977 SENSORY LOSS 20
978 SEROTONIN SYNDROME 20
979 TOOTH LOSS 20
980 UTERINE HAEMORRHAGE 20
981 WERNICKE^S ENCEPHALOPATHY 20
982 AXILLARY PAIN 19
983 BLOOD PRESSURE SYSTOLIC INCREASED 19
984 BODY HEIGHT DECREASED 19
985 CHOKING SENSATION 19
986 COELIAC DISEASE 19
987 DEPRESSIVE SYMPTOM 19
988 DEVICE DISLOCATION 19
989 DUODENITIS 19
990 EXOSTOSIS 19
991 HAEMATOCRIT INCREASED 19
992 HAIR GROWTH ABNORMAL 19
993 HYPERVOLAEMIA 19
994 HYPOKINESIA 19
995 HYPOTHERMIA 19
996 INCREASED TENDENCY TO BRUISE 19
997 INJECTION RELATED REACTION 19
998 IRON DEFICIENCY ANAEMIA 19
999 LEUKOPENIA 19